Imexon

From Self-sufficiency
Jump to: navigation, search
Imexon
File:Imexon.svg
Systematic (IUPAC) name
4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
Identifiers
CAS Number 59643-91-3
ATC code none
PubChem CID 68791
Chemical data
Formula C4H5N3O
Molar mass 111.102 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Imexon (INN, trade name Amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. It is a cyanoaziridine derivative.

External links

  • Amplimexon entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".